Deployment of American Heart Association Heart Failure Protocols and Content Within the Intel® Health Guide System

NCT ID: NCT01275846

Last Updated: 2022-03-31

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-06-30

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This purposed of this study is to ascertain if the implementation of remote patient management systems utilizing American Heart Association (AHA) guideline-based heart failure protocols and educational content can improve the management of patients with congestive heart failure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective, comparative study uses a pre-post test design to ascertain if the implementation of remote patient management systems utilizing AHA guideline-based heart failure protocols and educational content can successfully address the following objectives:

* validate the suitability of the Intel Health Guide to deploy AHA guideline-based patient care protocols and health content to patients managing congestive heart failure
* confirm that the AHA protocols as deployed on the HGS are supportive for clinicians following the AHA guidelines in a telehealth environment
* validate and verify that the data intended to be collected was effectively collected
* measure patient and provider satisfaction with use of the system

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Failure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Health Guide using AHA protocols

Participants in the study will receive the use of the Intel Health Guide, a telehealth device, with AHA customized heart failure protocols, response algorithms and educational content. Participants interact with the Intel Health Guide device, receiving immediate feedback when transmitting vitals measures and health question responses to a site monitored by their nurse case managers. Nurse case managers review and address concerns raised in vitals and/or question responses through standard care protocols established by their institution. Nurse case managers strive to enhance the participants quality of life, support continuity of care, facilitate provision of services in the appropriate setting to promote positive health outcomes.

Group Type EXPERIMENTAL

Health Guide using AHA heart failure protocols and content

Intervention Type DEVICE

Participants in the study will receive the use of the Intel Health Guide, a telehealth device, with AHA customized heart failure protocols, response algorithms and educational content. Participants interact with the Intel Health Guide device, receiving immediate feedback when transmitting vitals measures and health question responses to a site monitored by their nurse case managers. Nurse case managers review and address concerns raised in vitals and/or question responses through standard care protocols established by their institution. Nurse case managers strive to enhance the participants quality of life, support continuity of care, facilitate provision of services in the appropriate setting to promote positive health outcomes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Health Guide using AHA heart failure protocols and content

Participants in the study will receive the use of the Intel Health Guide, a telehealth device, with AHA customized heart failure protocols, response algorithms and educational content. Participants interact with the Intel Health Guide device, receiving immediate feedback when transmitting vitals measures and health question responses to a site monitored by their nurse case managers. Nurse case managers review and address concerns raised in vitals and/or question responses through standard care protocols established by their institution. Nurse case managers strive to enhance the participants quality of life, support continuity of care, facilitate provision of services in the appropriate setting to promote positive health outcomes.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Intel Health Guide

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has a diagnosis of Heart Failure NYHA and is currently in functional class II- IV status.
* Patient has been hospitalized for an episode of acute HF decompensation within the last 30 days.
* Patients with other co-morbidities such as atrial fibrillation, diabetes, coronary artery disease, COPD, hypertension, may be included in this evaluation. These conditions shall be documented during enrollment.
* Have telephone line or broadband internet availability to connect Intel® Health Guide.
* Are physically and mentally capable to complete the monitoring process or have a caregiver capable of assisting in the use of the Intel® Health Guide.
* Will be willing and able to sign an informed consent form to participate in this evaluation for a duration of 60 days.
* Live within a reasonable distance (30 miles or less) from the institution.

Exclusion Criteria

* Have a life expectancy of less than six months.
* Live in a nursing home or other multi-member assisted living facility.
* Intend to be away from their home for more than 2 weeks (14 days) total during the 60 days.
* Are unable to read English at a minimum 5th grade level.
* Do not live within a reasonable distance (30 miles or less) from the institution.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Intel Corporation

INDUSTRY

Sponsor Role collaborator

American Heart Association

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ileana L. Piña

Professor of Medicine & Epidemiology and Population Health, Albert Einstein College of Medicine, Montefiore Medical Center

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

George E Kikano, MD, CPE

Role: PRINCIPAL_INVESTIGATOR

Chair, Dept. of Family Medicine, Case Western Reserve University/University Hospitals

Ileana L Piña, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Professor, Medicine & Epi/Biostats, Case Western Reserve University/University Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals Home Care Services

Warrensville Heights, Ohio, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Related Links

Access external resources that provide additional context or updates about the study.

http://www.heart.org

The American Heart Association's mission is to build healthier lives, free of cardiovascular diseases and stroke.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

RES116137

Identifier Type: OTHER

Identifier Source: secondary_id

AHA100602

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Heart at Home- a Self-care Study
NCT01759368 COMPLETED NA